High serum YKL-40 level is associated with poor prognosis in patients with lung cancer

ÇİLEDAĞ A., Akin Kabalak P., ÇELİK G., Demir N., YÜKSEL C., Koycu G., ...Daha Fazla

TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, cilt.66, sa.4, ss.273-279, 2018 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 66 Sayı: 4
  • Basım Tarihi: 2018
  • Doi Numarası: 10.5578/tt.67319
  • Dergi Adı: TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.273-279
  • Anahtar Kelimeler: Lung cancer, chronic obstructive pulmonary disease, prognosis, YKL-40, BIOMARKER
  • Ankara Üniversitesi Adresli: Evet

Özet

Introduction: YKL-40 is a glycoprotein that plays role in inflammation and malignant processes. High serum YKL-40 levels are associated with short survive in cancer and chronic obstructive pulmonary disease (COPD) is another reason to increase it's level. However, limited knowledges are known in YKL-40 along with lung cancer and COPD.